Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy

	Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy
刊名	CHINESE JOURNAL OF CANCER RESEARCH
	2017
卷号	29
关键词	PAINFUL DIABETIC-NEUROPATHY DOUBLE-BLIND PLACEBO PREVENTION MANAGEMENT TRIAL GABAPENTIN PREGABALIN ONCOLOGY TAXANES Duloxetine FACT-Tax Scales paclitaxel peripheral neuropathy
ISSN号	1000-9604
其他题名	Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy
英文摘要	Objective: Chemotherapy with paclitaxel is associated with significant neurotoxicity that may offset patients' quality of life and therapeutic benefits. This prospective, non-randomized control study evaluated the efficacy and safety of an antidepressant drug, duloxetine, at 30 or 60 mg/d, in the treatment of paclitaxel-induced peripheral neuropathy (PIPN) in Chinese breast cancer patients.
语种	英语
CSCD记录号	CSCD:6101481
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/50031]
专题	中国科学院合肥物质科学研究院
推荐引用方式 GB/T 7714	. Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy[J]. CHINESE JOURNAL OF CANCER RESEARCH,2017,29.
APA	(2017).Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy.CHINESE JOURNAL OF CANCER RESEARCH,29.
MLA	"Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy".CHINESE JOURNAL OF CANCER RESEARCH 29(2017).